Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis

JAMA Psychiatry
Britta GallingC U Correll

Abstract

Antipsychotics are used increasingly in youth for nonpsychotic and off-label indications, but cardiometabolic adverse effects and (especially) type 2 diabetes mellitus (T2DM) risk have raised additional concern. To assess T2DM risk associated with antipsychotic treatment in youth. Systematic literature search of PubMed and PsycINFO without language restrictions from database inception until May 4, 2015. Data analyses were performed in July 2015, and additional analyses were added in November 2015. Longitudinal studies reporting on T2DM incidence in youth 2 to 24 years old exposed to antipsychotics for at least 3 months. Two independent investigators extracted study-level data for a random-effects meta-analysis and meta-regression of T2DM risk. The coprimary outcomes were study-defined T2DM, expressed as cumulative T2DM risk or as T2DM incidence rate per patient-years. Secondary outcomes included the comparison of the coprimary outcomes in antipsychotic-treated youth with psychiatric controls not receiving antipsychotics or with healthy controls. Thirteen studies were included in the meta-analysis, including 185,105 youth exposed to antipsychotics and 310,438 patient-years. The mean (SD) age of patients was 14.1 (2.1) years, and...Continue Reading

Citations

Apr 12, 2016·European Psychiatry : the Journal of the Association of European Psychiatrists·M Pérez-PiñarL Ayerbe
Jun 11, 2016·Journal of Child and Adolescent Psychopharmacology·Amit BaumelChristoph U Correll
Oct 14, 2016·Pediatric Annals·W David Lohr, V Faye Jones
Nov 3, 2016·Obesity·Richard C Shelton
Jul 9, 2016·Journal of Child and Adolescent Psychopharmacology·Yesie YoonCraig A Erickson
Mar 4, 2017·Acta Psychiatrica Scandinavica·A G SzmulewiczS A Strejilevich
Mar 17, 2018·Hormone Molecular Biology and Clinical Investigation·Kai G KahlUlrich Schweiger
Mar 22, 2018·European Journal of Endocrinology·Clare A WhicherRichard I G Holt
Nov 25, 2017·European Archives of Psychiatry and Clinical Neuroscience·J RuppertK G Kahl
Aug 12, 2017·Journal of Child and Adolescent Psychopharmacology·Shan Xing, Todd A Lee
Jun 12, 2018·Journal of Child and Adolescent Psychopharmacology·Yasuyuki OkumuraJunzo Iida
Oct 26, 2018·Evidence-based Mental Health·Benedetto Vitiello, Chiara Davico
Nov 20, 2018·Journal of Child and Adolescent Psychopharmacology·Marco PozziSonia Radice
Nov 15, 2018·Journal of Psychiatric Practice·Sara B VanbronkhorstKelly Blankenship
Oct 7, 2017·The British Journal of Psychiatry : the Journal of Mental Science·Toby PillingerOliver D Howes
Jun 11, 2019·Clinical Pediatrics·Rachel Ballard, Nia Heard-Garris
Dec 19, 2019·Journal of Child and Adolescent Psychopharmacology·Jennifer D HaydenMelissa P DelBello
Dec 19, 2019·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A A Portnova, Yu P Sivolap
Jun 3, 2018·Archives of Pharmacal Research·Mou-Ze LiuWei Zhang
Jun 27, 2020·Frontiers in Psychiatry·Larissa DorettoAna Cristina Chaves
Aug 26, 2020·European Child & Adolescent Psychiatry·Casper C L van der EschBram Dierckx

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.